Carvedilol inhibits platelet-derived growth factor-induced signal transduction in human cardiac fibroblasts

Journal of Cardiovascular Pharmacology

Volumn 39, Issue 4, 2002, Pages 576-589

  Lotze, Ulrich ^a   Heinke, Stefan ^a   Fritzenwanger, Michael ^a   Krack, Andreas ^a   Müller, Siegfried ^a   Figulla, Hans R ^a  

^a Medizinische Klinik I   (Germany)

Author keywords

Carvedilol; Derived growth factor; DNA synthesis; Human cardiac fibroblasts; Platelet; Signal transduction; Tyrosine kinase inhibition

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL; PHOSPHOTRANSFERASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROPRANOLOL; RECOMBINANT PROTEIN;

ARTICLE; AUTOPHOSPHORYLATION; CELL CULTURE; COLORIMETRY; CONCENTRATION RESPONSE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ENZYME ACTIVATION; FIBROBLAST; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; INHIBITION KINETICS; MEASUREMENT; MITOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; DNA; FIBROBLASTS; HUMANS; MYOCARDIUM; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROPANOLAMINES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 0036199527     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200204000-00014     Document Type: Article

References (44)

1. The extracellular matrix in human myocardium: Part I: Collagen I, II, VI, and IV
2. The extracellular matrix in human cardiac tissue: Part II: Vimentin, laminin, and fibronectin
3. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue
4. Pathologic hypertrophy with fibrosis: The structural basis for myocardial failure
5. Remodeling and reparation of the cardiovascular system
6. Mechanical load and polypeptide growth factors stimulate cardiac fibroblast activity
7. Mechanisms of atherosclerosis: A review
8. The pathogenesis of atherosclerosis: A perspective for the 1990s
9. Pathogenesis of pulmonary fibrosis in interstitial lung disease
10. Platelet-derived growth factor and proliferative glomerulonephritis
11. Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation
12. Selective platelet derived growth factor receptor kinase blockers reverse sistransformation
13. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection
14. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury
15. Carvedilol inhibits vascular smooth muscle cell proliferation
16. Carvedilol, a multiple-action neurohumoral antagonist, inhibits mitogen-activated protein kinase and cell cycle progression in vascular smooth muscle cells
17. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
18. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
19. Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake
20. An enzyme-linked immunoabsorbent assay for bromodeoxyuridine incorporation using fixed microcultures
21. Measurement of antigen specific lymphocyte proliferation using 5-bromodeoxyuridine incorporation: An easy and low cost alternative to radioactive thymidine incorporation
22. Quantification of 5-bromo2-deoxyuridine incorporation into DNA an enzyme immunoassay for the assessment of the lymphoid cell proliferative response
23. Experimental diffuse interstitial renal fibrosis: A biochemical approach
24. Isolation and characterisation of human cardiac fibroblasts from explanted adult hearts
25. Replicative senescence of human fibroblast-like cells in culture
26. Carvedilol: A novel drug with multiple actions
27. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger
28. mapk are required for fibroblast proliferation
29. Inhibition of human cardiac fibroblast mitogenesis by blockade of mitogen activated protein kinase and phosphatidylinositol 3-kinase
30. Mitogen-activated kinases: Versatile transducers for cell signaling
31. Signal transduction within the nucleus by mitogen-activated kinase
32. Inhibition of human vascular smooth muscle cell proliferation by the novel multiple-action antihypertensive agent carvedilol
33. Effect of calcium channel blockers on the growth of human vascular smooth muscle cells derived from saphenous vein and vascular graft stenoses
34. Alpha1-receptor antagonists urapidil and prazosin inhibit neointima formation in rat carotid artery induced by balloon catheter injury
35. Pharmaco kinetics of carvedilol in humans
36. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
37. Effect of carvedilol on survival in severe chronic heart failure
38. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease
39. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure
40. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: The CAPRICORN randomised trial
41. Effect of carvedilol on left ventricular function and mass in hypertension
42. Remodeling of the rat right and left ventricles in experimental hypertension
43. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction
44. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction